# The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction

> **NCT01172171** · PHASE2 · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 41 (actual)

## Conditions studied

- Acute Myocardial Infarction
- Ischemia-reperfusion Injury

## Interventions

- **DRUG:** Melatonin, N-acetyl-5-methoxytryptamine
- **DRUG:** Isotonic saline, Natrium chloride

## Key facts

- **NCT ID:** NCT01172171
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-12
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2017-01-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01172171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01172171, "The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01172171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*